Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administration of Colchicine Plus Standard Treatment vs. Standard Therapy, in Hospitalized Patients With COVID-19, Within the First 48 Hours, and no Severity Criteria.

NCT04350320 is registered in ClinicalTrials.gov with Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia as lead sponsor.

NCT NCT04350320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04350320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administration of Colchicine Plus Standard Treatment vs. Standard Therapy, in Hospitalized Patients With COVID-19, Within the First 48 Hours, and no Severity Criteria.
Lead sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2020
Completion date
December 30, 2020
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19